Zura Bio ZURA
NASDAQ ZURA
$4.13 +0.00 (+0.00%)
As of: Oct 22, 2026 · 11:34 AM EDT

Zura Bio (ZURA) EBITDA (2024 - 2026)

Updated

Zura Bio (ZURA) recorded EBITDA of -$29.34 million in Q2 2026, compared with -$18.07 million a year earlier.

Analysis

Zura Bio (ZURA) EBITDA (2024 - 2026) Analysis & Trends

On a TTM basis, Zura Bio's EBITDA came in at -$92.7 million as of Jun 30, 2026; for FY2025, it was -$75.2 million.

  • Across earlier years, EBITDA came in at -$55.18 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly EBITDA in data going back to Q3 2024.
  • Per Business Quant, the preceding three quarters came in at -$25.48 million (Q1 2026), -$18.4 million (Q4 2025) and -$19.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn 9.10 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 8.33 Bn
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn -
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn 5.09 Bn
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn -9.70 Bn
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn 5.89 Bn
10 Zura Bio 523.07 Mn -156.09 Mn - -29.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.34 Mn
Mar 31, 2026 -25.48 Mn
Dec 31, 2025 -18.40 Mn
Sep 30, 2025 -19.49 Mn
Jun 30, 2025 -18.07 Mn
Mar 31, 2025 -19.25 Mn
Dec 31, 2024 -15.73 Mn
Sep 30, 2024 -19.32 Mn
API Access

Zura Bio EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ZURA&period=max&api_key=YOUR_API_KEY